Matrix Metalloproteinases in Predicting Nonproliferative Diabetic Retinopathy in Old Age

The development of diabetic retinopathy is associated with matrix metalloproteinases, but they are rarely used to predict this pathology. The purpose of the study is to predict the development of nonproliferative diabetic retinopathy in old age based on the level of matrix metalloproteinases in bloo...

Full description

Bibliographic Details
Main Authors: O. L. Fabikantov, I. V. Lev, N. M. Agarkov, R. E. Osmanov
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2023-01-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/1989
_version_ 1797875383211655168
author O. L. Fabikantov
I. V. Lev
N. M. Agarkov
R. E. Osmanov
author_facet O. L. Fabikantov
I. V. Lev
N. M. Agarkov
R. E. Osmanov
author_sort O. L. Fabikantov
collection DOAJ
description The development of diabetic retinopathy is associated with matrix metalloproteinases, but they are rarely used to predict this pathology. The purpose of the study is to predict the development of nonproliferative diabetic retinopathy in old age based on the level of matrix metalloproteinases in blood plasma. The main group of the study consisted of 63 patients 60–74 years old with nonproliferative diabetic retinopathy, control consisted of 56 patients of the same age without the diabetic retinopathy and other ophthalmopathology at present and in history. Examination of patients in both groups included: tonometry, visiometry, standard fundus photography, optical coherence tomography, optical coherence tomography-A, fluorescence angiography. Determination of matrix metalloproteinases was carried out by the method of enzyme-linked immunosorbent assay. A statistically significant increase in matrix metalloproteinase was found — 9 in the main group of patients to 55,7 ± 2.6 ng / ml versus 40.2 ± 1.9 ng / ml in age control, matrix metalloproteinase — 2 to 269.8 ± 1.2 ng / ml versus 221.9 ± 3.6 ng / ml, respectively. Based on the level of matrix metalloproteinases — 2 (X1) and (X2) of the blood by the regressive method for predicting the development of diabetic retinopathy, which has the form Y = 28.315 + 3.892 × X1 + 2.453 × X2, which will allow detecting the disease at an early stage.
first_indexed 2024-04-10T01:45:43Z
format Article
id doaj.art-84883a3fbd6345f3bb1b4ef12f244363
institution Directory Open Access Journal
issn 1816-5095
2500-0845
language Russian
last_indexed 2024-04-10T01:45:43Z
publishDate 2023-01-01
publisher Ophthalmology Publishing Group
record_format Article
series Oftalʹmologiâ
spelling doaj.art-84883a3fbd6345f3bb1b4ef12f2443632023-03-13T09:08:43ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452023-01-0119480380710.18008/1816-5095-2022-4-803-807975Matrix Metalloproteinases in Predicting Nonproliferative Diabetic Retinopathy in Old AgeO. L. Fabikantov0I. V. Lev1N. M. Agarkov2R. E. Osmanov3Тамбовский филиал ФГАУ НМИЦ «МНТК “Микрохирургия глаза” им. академика С.Н. Федорова» Министерства здравоохранения Российской ФедерацииТамбовский филиал ФГАУ НМИЦ «МНТК “Микрохирургия глаза” им. академика С.Н. Федорова» Министерства здравоохранения Российской ФедерацииФГБОУ ВО «Юго-Западный государственный университет»Тамбовский филиал ФГАУ НМИЦ «МНТК “Микрохирургия глаза” им. академика С.Н. Федорова» Министерства здравоохранения Российской ФедерацииThe development of diabetic retinopathy is associated with matrix metalloproteinases, but they are rarely used to predict this pathology. The purpose of the study is to predict the development of nonproliferative diabetic retinopathy in old age based on the level of matrix metalloproteinases in blood plasma. The main group of the study consisted of 63 patients 60–74 years old with nonproliferative diabetic retinopathy, control consisted of 56 patients of the same age without the diabetic retinopathy and other ophthalmopathology at present and in history. Examination of patients in both groups included: tonometry, visiometry, standard fundus photography, optical coherence tomography, optical coherence tomography-A, fluorescence angiography. Determination of matrix metalloproteinases was carried out by the method of enzyme-linked immunosorbent assay. A statistically significant increase in matrix metalloproteinase was found — 9 in the main group of patients to 55,7 ± 2.6 ng / ml versus 40.2 ± 1.9 ng / ml in age control, matrix metalloproteinase — 2 to 269.8 ± 1.2 ng / ml versus 221.9 ± 3.6 ng / ml, respectively. Based on the level of matrix metalloproteinases — 2 (X1) and (X2) of the blood by the regressive method for predicting the development of diabetic retinopathy, which has the form Y = 28.315 + 3.892 × X1 + 2.453 × X2, which will allow detecting the disease at an early stage.https://www.ophthalmojournal.com/opht/article/view/1989диабетическая ретинопатияматриксные металлопротеиназыпожилой возрастпрогнозирование
spellingShingle O. L. Fabikantov
I. V. Lev
N. M. Agarkov
R. E. Osmanov
Matrix Metalloproteinases in Predicting Nonproliferative Diabetic Retinopathy in Old Age
Oftalʹmologiâ
диабетическая ретинопатия
матриксные металлопротеиназы
пожилой возраст
прогнозирование
title Matrix Metalloproteinases in Predicting Nonproliferative Diabetic Retinopathy in Old Age
title_full Matrix Metalloproteinases in Predicting Nonproliferative Diabetic Retinopathy in Old Age
title_fullStr Matrix Metalloproteinases in Predicting Nonproliferative Diabetic Retinopathy in Old Age
title_full_unstemmed Matrix Metalloproteinases in Predicting Nonproliferative Diabetic Retinopathy in Old Age
title_short Matrix Metalloproteinases in Predicting Nonproliferative Diabetic Retinopathy in Old Age
title_sort matrix metalloproteinases in predicting nonproliferative diabetic retinopathy in old age
topic диабетическая ретинопатия
матриксные металлопротеиназы
пожилой возраст
прогнозирование
url https://www.ophthalmojournal.com/opht/article/view/1989
work_keys_str_mv AT olfabikantov matrixmetalloproteinasesinpredictingnonproliferativediabeticretinopathyinoldage
AT ivlev matrixmetalloproteinasesinpredictingnonproliferativediabeticretinopathyinoldage
AT nmagarkov matrixmetalloproteinasesinpredictingnonproliferativediabeticretinopathyinoldage
AT reosmanov matrixmetalloproteinasesinpredictingnonproliferativediabeticretinopathyinoldage